During JADPRO Live Virtual 2020, Kirollos S. Hanna, PharmD, BCPS, BCOP, updated the audience on the pharmacology, new indications, and the clinical trial data of novel medications as well as expanded indications in solid tumors. Dr. Hanna also discussed signs and symptoms of potential serious and life-threatening adverse events, and how new therapeutic entities will impact the advanced practice setting.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087241 | PMC |
| http://dx.doi.org/10.6004/jadpro.2021.12.3.11 | DOI Listing |
Publication Analysis
Top Keywords
solid tumors
8
2019-2020 drug
4
drug updates
4
updates solid
4
tumors jadpro
4
jadpro live
4
live virtual
4
virtual 2020
4
2020 kirollos
4
kirollos hanna
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!